Damora Therapeutics Bolsters Leadership With CEO Appointment, $1.9M Equity Package
Damora Therapeutics appoints Jennifer Jarrett as CEO, grants her 2M share awards. Company also awards equity to four new employees under Nasdaq inducement rules.
DMRAclinical developmentrestricted stock units